Pakistan receives another 2 million doses of China-made Covid vaccine

The country hopes to enhance its immunisation drive.

Sinovac, Vaccine
Sinovac vaccine. Photo: Bloomberg
Press Trust of India Islamabad
2 min read Last Updated : Jun 23 2021 | 2:08 PM IST

Pakistan has received another two million doses of a China-made coronavirus vaccine, as the country hopes to enhance its immunisation drive.

A special flight of Pakistan International Airlines (PIA) PK-6852 airlifted two million doses of Sinovac COVID-19 vaccine from the Beijing Capital International Airport to Islamabad on Tuesday.

It is in addition to 1.55 million doses of Sinovac vaccines from China to Pakistan on Sunday.

According to the National Command and Operation Centre (NCOC), the main body to combat the virus, "The National Disaster Management Authority (NDMA) is spearheading the process of purchasing vaccines from the international market under the auspices of the NCOC.

The fresh doses will be sent to various vaccine centres across the country for which arrangements are already in place.

"With the arrival of this consignment, the daily average administering of doses across the country will be enhanced considerably," the NCOC said.

Meanwhile, the number of coronavirus cases in the country rose to 950,768 after 930 new cases were reported on Wednesday.

With 39 more deaths, the country coronavirus toll rose to 22,073, reported the Ministry of National Health Services.

Pakistani health authorities had launched a nationwide vaccination drive with around a million doses of Sinopharm vaccine donated by China, starting with older people and frontline healthcare workers, in March.

Initially, the government had to deal with vaccination hesitancy and a shortage of vaccine supplies and had limited shots for people aged 30 or over.

Now vaccines are available for people aged over 18 years.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 23 2021 | 2:08 PM IST

Next Story